Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
In a phase 3 trial of patients with previously untreated, advanced renal-cell carcinoma who had intermediate or poor prognostic risk, cabozantinib plus nivolumab and ipilimumab
In a phase 3 trial of patients with previously untreated, advanced renal-cell carcinoma who had intermediate or poor prognostic risk, cabozantinib plus nivolumab and ipilimumab
With or without ibrutinib, venetoclax–obinutuzumab was superior to chemoimmunotherapy as first-line treatment in fit patients (i.e., those with a low burden of coexisting conditions) with
In the POSITIVE trial of select women with previous hormone receptor–positive early breast cancer, temporary interruption of endocrine therapy to attempt pregnancy did not confer
Trifluridine–tipiracil (FTD–TPI) plus bevacizumab improved overall survival in patients with refractory metastatic colorectal cancer, researchers report, compared with FTD-TPI alone. “The safety profile of FTD–TPI
Blinatumomab, a bispecific T-cell engager molecule targeting CD19, was safe and had a high level of efficacy in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia
Regardless of the treatment chosen, men with localized prostate cancer had low mortality and similar outcomes after a median of 15 years of follow-up, researchers
In the DESTINY-Breast02 trial, patients with HER2-positive metastatic breast cancer had a favorable benefit-risk response to trastuzumab deruxtecan in comparison to treatment of physician’s choice,
“The best evidence is that racism does not cause prostate cells to become cancers, but once that malignant transformation takes place, the effects of racism
In a guideline from the American Society of Clinical Oncology, a multimodal, stepped-care approach is recommended for managing anxiety and depression in adult cancer survivors.
Writing that “the basic nature of immune checkpoint inhibitor therapy poses questions,” authors of a Sounding Board article outline a path toward forcing innovation in